Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Jianhua Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0326-3223; OpenAlex author ID A5064955096. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers

Papers 6

  1. Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer. Last author DOI 10.1136/jitc-2025-011890↗
  2. Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice. Last author DOI 10.1172/jci179014↗
  3. Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. Last author DOI 10.1053/j.gastro.2021.12.281↗
  4. B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.814312↗
  5. Black raspberries suppress pancreatic cancer through modulation of NKp46+, CD8+, and CD11b+ immune cells. Co-author DOI 10.1002/fft2.1↗
  6. Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials. Co-author DOI 10.3233/jbr-170159↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael A. Caligiuri · 3 shared papers, 2022–2025 · strength 0.62
  2. Kun‐Yu Teng · 3 shared papers, 2022–2025 · strength 0.48
  3. Zhenyu Dai · 2 shared papers, 2022–2025 · strength 0.35
  4. Zheng Gang Zhu · 3 shared papers, 2020–2022 · strength 0.34
  5. Li-Shu Wang · 2 shared papers, 2017–2025 · strength 0.31
  6. Zhixin Li · 1 shared paper, 2025 · strength 0.25
  7. Zahir Shah · 1 shared paper, 2025 · strength 0.25
  8. Laleh Golkar Melstrom · 1 shared paper, 2025 · strength 0.24
  9. Pan Pan · 2 shared papers, 2017–2020 · strength 0.18
  10. Dechun Li · 1 shared paper, 2022 · strength 0.11
  11. Xin Zhao · 1 shared paper, 2022 · strength 0.11
  12. Songbing He · 1 shared paper, 2022 · strength 0.11
  13. Yunyun Xu · 1 shared paper, 2022 · strength 0.11
  14. Vincent M. Chung · 1 shared paper, 2022 · strength 0.11
  15. Jian Zhou · 1 shared paper, 2022 · strength 0.11
  16. Mohammed Aldakkak · 1 shared paper, 2020 · strength 0.10
  17. Li‐Shu Wang · 1 shared paper, 2020 · strength 0.10
  18. Susan Tsai · 1 shared paper, 2020 · strength 0.10
  19. He Ren · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.